COVAD survey 2 long-term outcomes: unmet need and protocol

Fazal ZZ, Sen P, Joshi M, Ravichandran N, Lilleker JB, Agarwal V, Kardes S, Kim M, Day J, Makol A, Milchert M, Gheita T, Salim B, Velikova T, Gracia-Ramos AE, Parodis I, Nikiphorou E, Tan AL, Chatterjee T, Cavagna L, Saavedra MA, Shinjo SK, Ziade N, Selva-O'Callaghan A, Nune A, Knitza J, Kuwana M, Toro Gutierrez CE, Vinicio Caballero-Uribe C, Dey D, Distler O, Chinoy H, Agarwal V, Aggarwal R, Gupta L (2022)

Publication Type: Journal article

Publication year: 2022

Journal

DOI: 10.1007/s00296-022-05157-6

Abstract

Vaccine hesitancy is considered a major barrier to achieving herd immunity against COVID-19. While multiple alternative and synergistic approaches including heterologous vaccination, booster doses, and antiviral drugs have been developed, equitable vaccine uptake remains the foremost strategy to manage pandemic. Although none of the currently approved vaccines are live-attenuated, several reports of disease flares, waning protection, and acute-onset syndromes have emerged as short-term adverse events after vaccination. Hence, scientific literature falls short when discussing potential long-term effects in vulnerable cohorts. The COVAD-2 survey follows on from the baseline COVAD-1 survey with the aim to collect patient-reported data on the long-term safety and tolerability of COVID-19 vaccines in immune modulation. The e-survey has been extensively pilot-tested and validated with translations into multiple languages. Anticipated results will help improve vaccination efforts and reduce the imminent risks of COVID-19 infection, especially in understudied vulnerable groups.

Authors with CRIS profile

Involved external institutions

Aga Khan University Hospital Pakistan (PK) Maulana Azad Medical College (MAMC) India (IN) Byramjee Jeejeebhoy Government Medical College & Sassoon General Hospital India (IN) Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS) India (IN) University of Manchester United Kingdom (GB) Mahatma Gandhi Mission Institute of Health Sciences (MGMIHS) India (IN) Istanbul University / İstanbul Üniversitesi Turkey (TR) University of Illinois College of Medicine United States (USA) (US) Royal Melbourne Hospital (RMH) Australia (AU) Mayo Clinic United States (USA) (US) Pomeranian Medical University / Pomorski Uniwersytet Medyczny w Szczecinie (PMU) Poland (PL) Cairo University Egypt (EG) Fauji Foundation Hospital Pakistan (PK) Hl. Kliment Ochridski-Universität Sofia Bulgaria (BG) Instituto Mexicano del Seguro Social Mexico (MX) Karolinska Institute Sweden (SE) King’s College London United Kingdom (GB) Leeds Teaching Hospitals NHS Trust United Kingdom (GB) Policlinico San Matteo Pavia Fondazione IRCCS Italy (IT) University of São Paulo / Universidade de São Paulo (USP) Brazil (BR) Université Saint-Joseph (USJ) / جامعة القديس يوسف / Սուրբ Ժոզեֆի համալսարան Lebanon (LB) Southport and Ormskirk Hospital NHS Trust United Kingdom (GB) Autonomous University of Barcelona (UAB) / Universitat Autònoma de Barcelona Spain (ES) Nippon Medical School Japan (JP) Pontifical Xavierian University / Pontificia Universidad Javeriana Colombia (CO) Universidad del Norte Colombia (CO) University of Ghana Ghana (GH) University of Zurich / Universität Zürich (UZH) Switzerland (CH) University of Pittsburgh United States (USA) (US)

How to cite

APA:

Fazal, Z.Z., Sen, P., Joshi, M., Ravichandran, N., Lilleker, J.B., Agarwal, V.,... Gupta, L. (2022). COVAD survey 2 long-term outcomes: unmet need and protocol. Rheumatology International. https://dx.doi.org/10.1007/s00296-022-05157-6

MLA:

Fazal, Zoha Zahid, et al. "COVAD survey 2 long-term outcomes: unmet need and protocol." Rheumatology International (2022).

BibTeX: Download